Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that Humana, a major U.S. health insurer, has updated its coverage policy to include adolescents aged 15-21 in response to …
Humana Pioneers Coverage Expansion for Adolescent Depression Treatment Following FDA Clearance Read More
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) recently highlighted a compelling advantage in safety for its drug NRX-101, in comparison to the standard treatments offered in its latest clinical trial. …
NRx Pharmaceuticals Makes Significant Stride with New Depression Drug, Aims for Accelerated FDA Approval Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the publication of a groundbreaking study in the prestigious journal Brain Stimulation. The research provides new insights into the effectiveness of …
New Study Offers Hope for Depression Patients Undergoing TMS Therapy Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced that the last patient in its Phase 2b/3 study of NRX-101 recently completed their day 42 visit. The company is …
NRx Pharmaceuticals Nears Completion of Pivotal Trial for Bipolar Depression Treatment Read More